V022-0677 Screening compound: 3-methoxy-N-(3-methylbutyl)-N-[2-oxo-2-(4-{[4-(propan-2-yl)phenoxy]methyl}-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl)ethyl]benzamide

V022-0677 Screening compound: 3-methoxy-N-(3-methylbutyl)-N-[2-oxo-2-(4-{[4-(propan-2-yl)phenoxy]methyl}-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl)ethyl]benzamide
V022-0677 Screening compound: 3-methoxy-N-(3-methylbutyl)-N-[2-oxo-2-(4-{[4-(propan-2-yl)phenoxy]methyl}-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-0677
3-methoxy-N-(3-methylbutyl)-N-[2-oxo-2-(4-{[4-(propan-2-yl)phenoxy]methyl}-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-0677

Molecular Formula

C32H40N2O4S (C32 H40 N2 O4 S)

Compound Name

3-methoxy-N-(3-methylbutyl)-N-[2-oxo-2-(4-{[4-(propan-2-yl)phenoxy]methyl}-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl)ethyl]benzamide

IUPAC name

3-methoxy-N-(3-methylbutyl)-N-[2-oxo-2-(4-{[4-(propan-2-yl)phenoxy]methyl}-4H5H6H7H-thieno[32-c]pyridin-5-yl)ethyl]benzamide

SMILES

CC(C)CCN(CC(N(CC1)C(COc2ccc(C(C)C)cc2)c2c1scc2)=O)C(c1cc(OC)ccc1)=O

InChI

InChI=1S/C32H40N2O4S/c1-22(2)13-16-33(32(36)25-7-6-8-27(19-25)37-5)20-31(35)34-17-14-30-28(15-18-39-30)29(34)21-38-26-11-9-24(10-12-26)23(3)4/h6-12,15,18-19,22-23,29H,13-14,16-17,20-21H2,1-5H3/t29-/m0/s1

InChI Key

TYBWUOUPTNCJAX-LJAQVGFWSA-N

MDL Number (MFCD)

MFCD19865563

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

548.75

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.905

Distribution Coefficient, logD

6.905

Water Solubility, LogSw

-5.78

Polar Surface Area

47.808

Acid Dissociation Constant (pKa)

22.75

Base Dissociation Constant (pKb)

2.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

43.80

V022-0677 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V022-0677 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-0677?
Check Price and Availability of V022-0677, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-0677 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-0677
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-0677
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-0677 available by request